Literature DB >> 14710025

[Guillain-Barré syndrome revealing visceral leishmaniasis in an immunocompetent woman].

S Attarian1, J Serratrice, C Mazodier, P Disdier, J-P Azulay, J Pouget.   

Abstract

Visceral leishmaniasis is an endemic parasitic infection rarely observed in association with Guillain-Barré syndrome in immunocompetent patients. A 40-year-old immunocompetent woman was admitted to our unit with recent onset difficulty in walking. The neurological examination and electrophysiological study led to the diagnosis of Guillain-Barré syndrome. During hospitalization, she developed cytopenia involving all three lines revealing visceral leishmaniasis. A few cases of visceral leishmaniasis with neuropathy have been reported, mainly in tropical regions. Neuropathological manifestations of visceral leishmaniasis are probably underestimated. The question is whether Guillain-Barré syndrome and visceral leishmaniasis are causally related.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14710025

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  3 in total

Review 1.  Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis.

Authors:  Melanie Walker; James G Kublin; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-11-23       Impact factor: 9.079

2.  Unveiling Cerebral Leishmaniasis: parasites and brain inflammation in Leishmania donovani infected mice.

Authors:  Guilherme D Melo; Sophie Goyard; Laurence Fiette; Alexandre Boissonnas; Christophe Combadiere; Gisele F Machado; Paola Minoprio; Thierry Lang
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

3.  The impact of leishmaniasis on mental health and psychosocial well-being: A systematic review.

Authors:  Malini Pires; Barry Wright; Paul M Kaye; Virgínia da Conceição; Rachel C Churchill
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.